Two Sigma Securities »

Aclaris Therapeutics shares owned by Two Sigma Securities

Quarter-by-quarter ownership of Aclaris Therapeutics (ACRS) shares owned by Two Sigma Securities from 13F filings

Historical chart of Two Sigma Securities investment in Aclaris Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aclaris Therapeutics held by Two Sigma Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aclaris Therapeutics by Two Sigma Securities

Quarter filed Position value Share count Share price at filing
2024-03-31 $20k 16k 1.24

More positions owned by Two Sigma Securities

NVIDIA Corporation Call Option (NVDA)
Meta Platforms Cl A Call Option (META)
Microsoft Corporation (MSFT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Amazon (AMZN)
Tesla Motors Call Option (TSLA)
Apple Call Option (AAPL)
Chevron Corporation (CVX)
Advanced Micro Devices Call Option (AMD)
Netflix Call Option (NFLX)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Broadcom (AVGO)
Super Micro Computer Call Option (SMCI)
Eli Lilly & Co. Call Option (LLY)
Lockheed Martin Corporation Call Option (LMT)

View all positions for Two Sigma Securities

Top funds holding Aclaris Therapeutics

BML Capital Management
BlackRock
Vanguard Group
D. E. Shaw & Co
Millennium Management
Bain Capital Life Sciences Investors
Rock Springs Capital Management
Acadian Asset Management
Geode Capital Management
Two Sigma Advisers
Two Sigma Investments
Qube Research & Technologies
Citadel Advisors
Deutsche Bank Aktiengesellschaft
Samsara BioCapital

View all funds holding Aclaris Therapeutics